Ignite Creation Date:
2024-05-06 @ 4:29 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05008939
Status:
UNKNOWN
Last Update Posted:
2021-08-17
First Post:
2021-07-25
Brief Title:
Sevoflurane for Treatment-Resistant Depression
Sponsor:
Shanghai First Maternity and Infant Hospital
Organization:
Shanghai First Maternity and Infant Hospital
Study Overview
Official Title:
Subanesthetic Sevoflurane for Treatment-Resistant Depression A Proof-of-Concept Trial
Status:
UNKNOWN
Status Verified Date:
2021-08
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study intends to carry out a prospective randomized double-blind placebo-controlled study to evaluate the efficacy and safety of subanesthetic sevoflurane for treatment-resistant depression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None